CXCL8 and colorectal carcinoma: To test if the drug combination–induced IL-8 attracts neutrophils and modulates the tumor-inhibitory effect, we knocked out IL-8 in 3 different CRC cell lines, including HCT116, DLD1, and RKO (Supplemental Figure 3, I and J).